These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 3538253

  • 21. [Effects of FK506 on aminonucleoside-induced nephrotic rats].
    Kawaguchi S.
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):141-51. PubMed ID: 1375300
    [Abstract] [Full Text] [Related]

  • 22. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
    Yang HD, Dong C, Guan FJ, Gao LL, Zhao T, Feng BF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
    [Abstract] [Full Text] [Related]

  • 23. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD, Bertram JF, Ryan GB.
    Exp Nephrol; 1995 Jun; 3(5):270-9. PubMed ID: 7583048
    [Abstract] [Full Text] [Related]

  • 24. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K, Yoshikawa N, Nakamura H, Itoh H.
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [Abstract] [Full Text] [Related]

  • 25. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM.
    Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
    [Abstract] [Full Text] [Related]

  • 26. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
    Olson JL, Rennke HG, Venkatachalam MA.
    Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat.
    Grond J, Elema JD.
    Lab Invest; 1981 Nov; 45(5):400-9. PubMed ID: 7300251
    [Abstract] [Full Text] [Related]

  • 29. Effects of saikosaponin-d on aminonucleoside nephrosis in rats.
    Abe H, Orita M, Konishi H, Arichi S, Odashima S.
    Eur J Pharmacol; 1986 Jan 21; 120(2):171-8. PubMed ID: 3948917
    [Abstract] [Full Text] [Related]

  • 30. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
    Tofovic SP, Rominski BR, Bastacky S, Jackso EK, Kost CK.
    Ren Fail; 2000 Mar 21; 22(2):159-79. PubMed ID: 10803761
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

  • 33. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
    Palluk R, Veress AT, Sonnenberg H.
    Pharmacology; 1989 Feb 28; 38(4):214-25. PubMed ID: 2526952
    [Abstract] [Full Text] [Related]

  • 34. Melatonin decreases apoptosis and expression of apoptosis-associated proteins in acute puromycin aminonucleoside nephrosis.
    Pedreañez A, Rincón J, Romero M, Viera N, Mosquera J.
    Nephrol Dial Transplant; 2004 May 28; 19(5):1098-105. PubMed ID: 14993511
    [Abstract] [Full Text] [Related]

  • 35. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
    Diamond JR, Pesek I.
    Lab Invest; 1991 Jan 28; 64(1):21-8. PubMed ID: 1990206
    [Abstract] [Full Text] [Related]

  • 36. Urinary kallikrein in experimental renal disease.
    Glasser RJ, Michael AF.
    Lab Invest; 1976 Jun 28; 34(6):616-22. PubMed ID: 933467
    [Abstract] [Full Text] [Related]

  • 37. Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis.
    Glasser RJ, Velosa JA, Michael AF.
    Lab Invest; 1977 May 28; 36(5):519-26. PubMed ID: 865079
    [Abstract] [Full Text] [Related]

  • 38. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
    Fukuda A, Fujimoto S, Iwatsubo S, Kawachi H, Kitamura K.
    Nephrology (Carlton); 2010 Apr 28; 15(3):321-6. PubMed ID: 20470301
    [Abstract] [Full Text] [Related]

  • 39. Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis.
    Whiteside CI, Cameron R, Munk S, Levy J.
    Am J Pathol; 1993 May 28; 142(5):1641-53. PubMed ID: 8494056
    [Abstract] [Full Text] [Related]

  • 40. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
    Kaplan BS, Renaud L, Drummond KN.
    Lab Invest; 1976 Feb 28; 34(2):174-8. PubMed ID: 1249918
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.